<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3052">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01752101</url>
  </required_header>
  <id_info>
    <org_study_id>1013-12</org_study_id>
    <nct_id>NCT01752101</nct_id>
  </id_info>
  <brief_title>Identification of a Plasma Proteomic Signature for Lung Cancer</brief_title>
  <official_title>Identification of a Plasma Proteomic Signature for Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integrated Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Integrated Diagnostics</source>
  <oversight_info>
    <authority>United States: Quorum Review IRB</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to identify a panel of plasma and/or serum proteins that
      differentiates the absence or presence of lung malignancy in samples obtained from subjects
      enrolled in this IRB/EC approved study with pulmonary nodules.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood samples are obtained from those patients undergoing procedures to determine if a lung
      nodule is benign or cancerous.  The data from the study will not be used to guide or
      influence the treatment of the patients enrolled in this study.  There is no change from the
      normal standard of care that patients receive.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Incidence rate of Non-Small Cell Lung Cancer</measure>
    <time_frame>24 months after enrollment</time_frame>
    <safety_issue>No</safety_issue>
    <description>The incidence rate of non-small cell lung cancer in the study population will be correlated to the predictive value of the Sponsor's blood test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Panel of proteins</measure>
    <time_frame>At the end of the study</time_frame>
    <safety_issue>No</safety_issue>
    <description>The positive and negative predictive value of the test to differentiate between malignancy and inflammatory diseases such as granulomatous disorders.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Precancerous Conditions</condition>
  <condition>Carcinoma</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing procedure for histologic diagnosis of lung nodule(s)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 40

          -  any smoking status, e.g. current, former, or never

          -  co-morbid conditions, e.g. COPD

          -  Nodule size ≥ 4 mm and ≤ 30 mm (up to Stage 2B eligible), any spiculation or ground
             glass opacity

          -  Pathology: malignant - adenocarcinoma, squamous, or large cell

          -  Pathology: benign - inflammatory (e.g. granulomatous, infectious) or non-inflammatory
             (e.g. hamartoma)

          -  Clinical stage, Primary tumor: ≤T2  (e.g. 1A, 1B, 2A and 2B)

          -  Clinical stage, Regional lymph nodes: N0 or N1 only

          -  Clinical stage, Distant metastasis: M0 only

        Exclusion Criteria:

          -  prior malignancy within 5 years of lung nodule diagnosis

          -  No nodule size available

          -  No pathology data available for those with

          -  Current diagnosis of non-small cell lung cancer

          -  Clinical stage: Primary tumor ≥T3; Regional lymph nodes: ≥N2; 4 Distant metastasis:
             ≥M1
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ken Fang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Integrated Diagnostics, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ken Fang, MD</last_name>
    <phone>206-576-6309</phone>
    <email>kfang@integrated-diagnostics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaiser Permanente Northern California</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Quyen Chau</last_name>
      <phone>415-833-3480</phone>
    </contact>
    <investigator>
      <last_name>Mark Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North East Alabama Regional Medical Center</name>
      <address>
        <city>Anniston</city>
        <state>Georgia</state>
        <zip>36207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Widdon, RN</last_name>
      <phone>256-235-5084</phone>
      <email>rwhiddon@rmccares.org</email>
    </contact>
    <investigator>
      <last_name>George Crawford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greater Baltimore Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Troy Gogoll</last_name>
      <phone>443-849-3123</phone>
      <email>tgogoll@gbmc.org</email>
    </contact>
    <investigator>
      <last_name>Neri Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lahey Hospital &amp; Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Gannon</last_name>
      <phone>781-744-2734</phone>
      <email>deborah.j.gannon@lahey.com</email>
    </contact>
    <investigator>
      <last_name>Christina Williamson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dusty Kah</last_name>
      <phone>313-916-1074</phone>
      <email>dkah1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Zane Hammoud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Karaus</last_name>
      <phone>507-538-8472</phone>
      <email>karats.mary@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>David Midthun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Steele</last_name>
      <phone>513-584-2951</phone>
      <email>steelers@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Sandra Starnes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Duane Shaffer</last_name>
      <phone>570-271-6866</phone>
      <email>dlshaffer@geisinger.edu,</email>
    </contact>
    <investigator>
      <last_name>Michael Ayers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiopulmonary Research Science and Technology Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Johnson</last_name>
      <phone>972-566-2648</phone>
      <email>mjohnson@cristi.org</email>
    </contact>
    <investigator>
      <last_name>Mitch Magee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Healthcare</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Flores</last_name>
      <phone>801-507-3609</phone>
      <email>jean.flores@imail.org</email>
    </contact>
    <investigator>
      <last_name>Michael Collins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Group Health Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Hansen</last_name>
      <phone>206-287-2453</phone>
      <email>hansen.ke@ghc.org</email>
    </contact>
    <investigator>
      <last_name>Jeff Sullivan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 24, 2013</lastchanged_date>
  <firstreceived_date>November 30, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Precancerous Conditions</keyword>
  <keyword>Carcinoma</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Precancerous Conditions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
